Design of a Phase 2, Randomized, Double-Blind, Placebo-Controlled, 24-Week, Parallel-Group Study of the Efficacy and Safety of Losmapimod in Treating Subjects with Facioscapulohumeral Muscular Dystrophy (FSHD): ReDUX4Alrabi Tawil,Michelle Mellion,Lucienne Ronco,Shane Raines,William Tracewell, Alisa Rahilly,Alejandro Rojas,Michelle Hage,Kathryn Wagner,Jeffrey Statland,Leo Wang,Teresinha Evangelista,Angela Genge,Summer Gibson,Namita Goyal,Johanna Hamel,Lawrence Hayward,Nicholas Johnson,Cornelia Kornblum,Hanns Lochmuller,Samantha LoRusso,Jordi Diaz Manera,Juan Vilchez Padilla,Alan Pestronk,Sabrina Sacconi,Benedikt Schoser,Perry Shieh,S. Subramony,Diego CadavidNEUROLOGY（2020）引用 4|浏览15暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
